advances-in-protein-chemistry

19. Meyer BS, Rademann J (2012) Extra- and intracellular imaging of human matrix metalloprotease 11 (hMMP-11) with a cell-penetrating FRET substrate.
J Biol Chem 287: 37857-37867.
20. Freije JM, Díez-Itza I, Balbín M, Sánchez LM, Blasco R, et al. (1994) Molecular cloning and expression of collagenase-3, a novel human matrix
metalloproteinase produced by breast carcinomas. J Biol Chem 269: 16766-16773.
21. Kudo Y, Iizuka S, Yoshida M, Tsunematsu T, Kondo T, et al. (2012) Matrix metalloproteinase-13 (MMP-13) directly and indirectly promotes tumor
angiogenesis. J Biol Chem 287: 38716-38728.
22. Yu G, Kovkarova-Naumovski E, Jara P, Parwani A, Kass D, et al. (2012) Matrix metalloproteinase-19 is a key regulator of lung fibrosis in mice and
humans. Am J Respir Crit Care Med 186: 752-762.
23. Saarialho-Kere U, Kerkelä E, Jahkola T, Suomela S, Keski-Oja J, et al. (2002) Epilysin (MMP-28) expression is associated with cell proliferation during
epithelial repair. J Invest Dermatol 119: 14-21.
24. Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, et al. (1995) Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation
of the activated form of the membrane metalloprotease. J Biol Chem 270: 5331-5338.
25. Deryugina EI, Ratnikov B, Monosov E, Postnova TI, DiScipio R, et al. (2001) MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3
promotes maturation of MMP-2 in breast carcinoma cells. Exp Cell Res 263: 209-223.
26. Sottrup-Jensen L, Birkedal-Hansen H (1989) Human fibroblast collagenase-alpha-macroglobulin interactions. Localization of cleavage sites in the bait
regions of five mammalian alpha-macroglobulins. J Biol Chem 264: 393-401.
27. Yang Z, Strickland DK, Bornstein P (2001) Extracellular matrix metalloproteinase 2 levels are regulated by the low density lipoprotein-related scavenger
receptor and thrombospondin 2. J Biol Chem 276: 8403-8408.
28. Bein K, Simons M (2000) Thrombospondin type 1 repeats interact with matrix metalloproteinase 2. Regulation of metalloproteinase activity. J Biol
Chem 275: 32167-32173.
29. Rodriguez-Manzaneque JC, Lane TF, Ortega MA, Hynes RO, Lawler J, et al. (2001) Thrombospondin-1 suppresses spontaneous tumor growth and
inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor. Proc Natl Acad Sci U S A 98: 12485-12490.
30. Wang Z, Juttermann R, Soloway PD (2000) TIMP-2 is required for efficient activation of proMMP-2 in vivo. J Biol Chem 275: 26411-26415.
31. Streuli C (1999) Extracellular matrix remodelling and cellular differentiation. Curr Opin Cell Biol 11: 634-640.
32. Giannelli G, Falk-Marzillier J, Schiraldi O, Stetler-Stevenson WG, Quaranta V (1997) Induction of cell migration by matrix metalloprotease-2 cleavage
of laminin-5. Science 277: 225-228.
33. Xu J, Rodriguez D, Petitclerc E, Kim JJ, Hangai M, et al. (2001) Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis
and tumor growth in vivo. J Cell Biol 154: 1069-1079.
34. Mañes S, Mira E, Barbacid MM, Ciprés A, Fernández-Resa P, et al. (1997) Identification of insulin-like growth factor-binding protein-1 as a potential
physiological substrate for human stromelysin-3. J Biol Chem 272: 25706-25712.
35. Mañes S, Llorente M, Lacalle RA, Gómez-Moutón C, Kremer L, et al. (1999) The matrix metalloproteinase-9 regulates the insulin-like growth factortriggered
autocrine response in DU-145 carcinoma cells. J Biol Chem 274: 6935-6945.
36. Whitelock JM, Murdoch AD, Iozzo RV, Underwood PA (1996) The degradation of human endothelial cell-derived perlecan and release of bound basic
fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases. J Biol Chem 271: 10079-10086.
37. Peschon JJ, Slack JL, Reddy P, Stocking KL, Sunnarborg SW, et al. (1998) An essential role for ectodomain shedding in mammalian development.
Science 282: 1281-1284.
38. Yu Q, Stamenkovic I (2000) Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and
angiogenesis. Genes Dev 14: 163-176.
39. Levi E, Fridman R, Miao HQ, Ma YS, Yayon A, et al. (1996) Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor
receptor 1. Proc Natl Acad Sci U S A 93: 7069-7074.
40. Codony-Servat J, Albanell J, Lopez-Talavera JC, Arribas J, Baselga J (1999) Cleavage of the HER2 ectodomain is a pervanadate-activable process
that is inhibited by the tissue inhibitor of metalloproteases-1 in breast cancer cells. Cancer Res 59: 1196-1201.
41. Vecchi M, Rudolph-Owen LA, Brown CL, Dempsey PJ, Carpenter G (1998) Tyrosine phosphorylation and proteolysis. Pervanadate-induced,
metalloprotease-dependent cleavage of the ErbB-4 receptor and amphiregulin. J Biol Chem 273: 20589-20595.
42. Nath D, Williamson NJ, Jarvis R, Murphy G (2001) Shedding of c-Met is regulated by crosstalk between a G-protein coupled receptor and the EGF
receptor and is mediated by a TIMP-3 sensitive metalloproteinase. J Cell Sci 114: 1213-1220.
43. Noë V, Fingleton B, Jacobs K, Crawford HC, Vermeulen S, et al. (2001) Release of an invasion promoter E-cadherin fragment by matrilysin and
stromelysin-1. J Cell Sci 114: 111-118.
44. Kajita M, Itoh Y, Chiba T, Mori H, Okada A, et al. (2001) Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J Cell
Biol 153: 893-904.
45. Westermarck J, Kähäri VM (1999) Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 13: 781-792.
46. Chandler S, Coates R, Gearing A, Lury J, Wells G, et al. (1995) Matrix metalloproteinases degrade myelin basic protein. Neurosci Lett 201: 223-226.
47. George SJ (2000) Therapeutic potential of matrix metalloproteinase inhibitors in atherosclerosis. Expert Opin Investig Drugs 9: 993-1007.
48. Arthur MJ (2000) Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis. Am J Physiol Gastrointest Liver Physiol 279: G245-249.
49. Thompson RW, Parks WC (1996) Role of matrix metalloproteinases in abdominal aortic aneurysms. Ann N Y Acad Sci 800: 157-174.
50. Saarialho-Kere UK, Vaalamo M, Puolakkainen P, Airola K, Parks WC, et al. (1996) Enhanced expression of matrilysin, collagenase, and stromelysin-1
in gastrointestinal ulcers. Am J Pathol 148: 519-526.
51. Rosenberg GA (1995) Matrix metalloproteinases in brain injury. J Neurotrauma 12: 833-842.
52. Golub LM, Wolff M, Roberts S, Lee HM, Leung M, et al. (1994) Treating periodontal diseases by blocking tissue-destructive enzymes. J Am Dent
Assoc 125: 163-169.
53. Corbel M, Boichot E, Lagente V (2000) Role of gelatinases MMP-2 and MMP-9 in tissue remodeling following acute lung injury. Braz J Med Biol Res
33: 749-754.
54. Konttinen YT, Ainola M, Valleala H, Ma J, Ida H, et al. (1999) Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial
membrane: different profiles in trauma and rheumatoid arthritis. Ann Rheum Dis 58: 691-697.
55. Hua J, Muschel RJ (1996) Inhibition of matrix metalloproteinase 9 expression by a ribozyme blocks metastasis in a rat sarcoma model system. Cancer
Res 56: 5279-5284.
OMICS Group eBooks
016